Celularity Inc. Increase (Decrease) in Inventories
Celularity Inc. (CELU) reported Increase (Decrease) in Inventories of -$10.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-04-30
- Celularity Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$1.73M.
- Celularity Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$2.31M.
- Celularity Inc. increase (decrease) in inventories for the quarter ending 2025-06-30 was -$3.66M.
- Celularity Inc. increase (decrease) in inventories for the quarter ending 2025-03-31 was -$2.55M.
- Celularity Inc. increase (decrease) in inventories for fiscal 2025 was -$10.25M.
- Celularity Inc. increase (decrease) in inventories for fiscal 2024 was -$6.28M, a 826.47% decline from fiscal 2023.
- Celularity Inc. increase (decrease) in inventories for fiscal 2023 was $865.00K, a 94.88% decline from fiscal 2022.
- Celularity Inc. increase (decrease) in inventories for fiscal 2022 was $16.89M, a 163.02% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | -$4.03M derived: sum of 2 quarters · filed 2026-04-30 | -$7.70M derived: sum of 3 quarters · filed 2026-04-30 | -$10.25M 10-K · filed 2026-04-30 |
| 2025-09-30 | -$2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$5.97M derived: sum of 2 quarters · filed 2025-11-14 | -$8.52M 10-Q · filed 2025-11-14 | -$9.15M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-06-30 | -$3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | -$6.21M 10-Q · filed 2025-08-29 | -$6.84M derived: sum of 3 quarters · filed 2026-04-30 | -$7.35M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-03-31 | -$2.55M 10-Q · filed 2025-08-29 | -$3.18M derived: sum of 2 quarters · filed 2026-04-30 | -$3.68M derived: sum of 3 quarters · filed 2026-04-30 | -$5.65M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | -$1.13M derived: sum of 2 quarters · filed 2026-04-30 | -$3.10M derived: sum of 3 quarters · filed 2026-04-30 | -$6.28M 10-K · filed 2026-04-30 |
| 2024-09-30 | -$503.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$2.47M derived: sum of 2 quarters · filed 2025-11-14 | -$5.65M 10-Q · filed 2025-11-14 | -$6.39M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-29 | -$5.15M 10-Q · filed 2025-08-29 | -$5.89M derived: sum of 3 quarters · filed 2025-08-29 | -$7.11M derived: sum of 4 quarters · filed 2025-08-29 |
| 2024-03-31 | -$3.18M 10-Q · filed 2025-08-29 | -$3.92M derived: sum of 2 quarters · filed 2025-08-29 | -$5.14M derived: sum of 3 quarters · filed 2025-08-29 | -$4.13M derived: sum of 4 quarters · filed 2025-08-29 |
| 2023-12-31 | -$740.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-08 | -$1.96M derived: sum of 2 quarters · filed 2025-05-08 | -$948.00K derived: sum of 3 quarters · filed 2025-05-08 | $865.00K 10-K · filed 2025-05-08 |
| 2023-09-30 | -$1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-06 | -$208.00K derived: sum of 2 quarters · filed 2024-12-06 | $1.60M 10-Q · filed 2024-12-06 | $1.67M derived: sum of 4 quarters · filed 2024-12-06 |
| 2023-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $2.82M 10-Q · filed 2024-11-07 | $2.88M derived: sum of 3 quarters · filed 2024-11-07 | $5.02M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-03-31 | $1.81M 10-Q · filed 2024-10-16 | $1.87M derived: sum of 2 quarters · filed 2024-10-16 | $4.01M derived: sum of 3 quarters · filed 2024-10-16 | $13.03M derived: sum of 4 quarters · filed 2024-10-16 |
| 2022-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | $2.20M derived: sum of 2 quarters · filed 2024-07-30 | $11.22M derived: sum of 3 quarters · filed 2024-07-30 | $16.89M 10-K · filed 2024-07-30 |
| 2022-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-03 | $11.16M derived: sum of 2 quarters · filed 2024-01-03 | $16.83M 10-Q · filed 2024-01-03 | $19.47M derived: sum of 4 quarters · filed 2024-01-03 |
| 2022-06-30 | $9.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $14.69M 10-Q · filed 2023-08-14 | $17.34M derived: sum of 3 quarters · filed 2023-08-14 | $19.43M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $5.67M 10-Q · filed 2023-05-22 | $8.31M derived: sum of 2 quarters · filed 2023-05-22 | $10.40M derived: sum of 3 quarters · filed 2023-05-22 | $10.93M derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $4.73M derived: sum of 2 quarters · filed 2023-03-31 | $5.26M derived: sum of 3 quarters · filed 2023-03-31 | $6.42M 10-K · filed 2023-03-31 |
| 2021-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $2.62M derived: sum of 2 quarters · filed 2022-11-10 | $3.78M 10-Q · filed 2022-11-10 | $3.68M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $526.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.69M 10-Q · filed 2022-08-09 | $1.59M derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $1.16M 10-Q · filed 2022-05-16 | $1.06M derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $643.00K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $745.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |